AbbVie is paying $650 million for a dual-targeting immunotherapy from China’s RemeGen. Elsewhere, Alnylam missed an earnings ...
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six research firms that are covering the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results